Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Last batch of monoclonal antibodies added to site

Thursday 26 January 2023

We have concluded our additions of monoclonal antibodies to the hepatology website. The following fifteen drugs have been added in this batch: 

Bronchodilators: Reslizumab.

Cancer Therapies: Ramucirumab, Sacituzumab govitecan, Trastuzumab, Trastuzumab deruxtecan, and Trastuzumab emtansine.

Immunosuppressants: Ravulizumab, Risankizumab, Secukinumab, Siltuximab, Tildrakizumab, Tralokinumab, Ustekinumab, and Vedolizumab.

Other: Romosozumab.

This brings our number of comedications up to 895, giving rise to 23,270 individual interactions.

Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016